In AML, a clear interrelation of p53 isoforms profile with clinical outcome [128] has been demonstrated, and, in melanoma, high levels of p53β and Δ40p53α isoforms were expressed in tumor cells but not in melanocytes or fibroblasts [129]. Here, TP53 is linked to melanoma.